Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H8O3S |
Molecular Weight | 208.234 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C1=CC=C2C=CC=CC2=C1
InChI
InChIKey=KVBGVZZKJNLNJU-UHFFFAOYSA-N
InChI=1S/C10H8O3S/c11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10/h1-7H,(H,11,12,13)
Sodium 2-naphthalenesulfonate is a sodium salt of naphthalene sulfonic acid. Sodium 2-naphthalenesulfonate is a surfactant-hydrotrope used in cosmetics. Use concentrations would be typically below 2%. In clinical studies, Sodium 2-naphthalenesulfonate was neither an irritant (tested up to 2%), cumulative irritant (tested up to 1%), nor a sensitizer (tested up to 1%). Sodium 2-naphthalenesulfonate is considered safe as used in cosmetic formulations intended to be applied to the skin.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Determination of cyclodextrins and their derivatives by capillary electrophoresis with indirect UV and conductivity detection. | 2001 Apr |
|
Protonation effects on the inclusion complexation of 6-deoxy-6-diethylamino-beta-cyclodextrin with 2-anthracenesulfonate, 2-naphthalenesulfonate, 2,6-naphthalenedisulfonate, and 2,7-naphthalenedisulfonate in aqueous solutions. | 2001 Jan |
|
Development of generic liquid chromatography-mass spectrometry methods using experimental design. | 2002 Jan |
|
Amplification of small analytes in polymer solution by capillary electrophoresis. | 2002 Jun |
|
Temperature-induced sedimentation to dispersion of ionic vesicles. | 2005 Apr 1 |
|
Decomposition of 2-naphthalenesulfonate in electroplating solution by ozonation with UV radiation. | 2005 Feb 14 |
|
Sorption enhancement of aromatic sulfonates onto an aminated hyper-cross-linked polymer. | 2005 May 1 |
|
Heterogeneity of the adsorption mechanism of low molecular weight compounds in reversed-phase liquid chromatography. | 2006 Aug 15 |
|
Nanostructuring of poly(diphenylamine) inside the galleries of montmorillonite organo clay through self-assembly approach. | 2006 Jun |
|
The role of cross-linking structures to the formation of one-dimensional nano-organized polyaniline and their Raman fingerprint. | 2008 Dec 1 |
|
trans-Diaqua-bis(ethyl-enediamine-κN,N')copper(II) bis[3-(3-pyrid-yl)propionate] dihydrate. | 2008 Mar 5 |
|
Photochemical elimination of leaving groups from zwitterionic intermediates generated via electrocyclic ring closure of alpha,beta-unsaturated anilides. | 2008 Nov 21 |
|
Influence of anionic sulfonate-containing co-ligands on the solid structures of silver complexes supported by 4,4'-bipyridine bridges. | 2008 Oct 21 |
|
Preparation of poly(1,5 diamino naphthalene) nanobelts/nanodiscs through a "hard-soft combined templates" approach. | 2010 Aug |
|
The development of electrically conductive polycaprolactone fumarate-polypyrrole composite materials for nerve regeneration. | 2010 Aug |
|
Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. | 2010 Aug 19 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14555418
In clinical studies, Sodium 2-naphthalenesulfonate was neither an irritant (tested up to 2%), cumulative irritant (tested up to 1%), nor a sensitizer (tested up to 1%).
Route of Administration:
Topical
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
120-18-3
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
204-375-3
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
44229
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
Naphthalene-2-sulfonic acid
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
8420
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
m7732
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | Merck Index | ||
|
C534215
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
O9S4K2S25E
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
DTXSID5044788
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY | |||
|
DB08254
Created by
admin on Fri Dec 15 18:38:05 GMT 2023 , Edited by admin on Fri Dec 15 18:38:05 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD